Amniotics was recently featured in Swedish TV4, in regard to development of our cell-therapeutic for COVID-19 diseases. Studies have shown that mesenchymal stem cells can reduce patients time in ventilators. Hence, with our potent and lung selected PulmiCell product, we trust that we can make a differences for patients in need.
Amniotics is featured on TV4 for their novel source of MSCs to treat COVID-19
In the News
3 July, 2020